View in EDS HTML Full Text PDF Full Text

Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation.

Saved in:

Bibliographic Details
Title:	Upfront use of eculizumab to treat early acute antibody‐mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Authors:	Schwotzer, Nora¹ (AUTHOR), Paganetti, Giulia¹ (AUTHOR), Barchi, Matteo¹ (AUTHOR), Perrottet, Nancy² (AUTHOR), Aubert, Vincent³ (AUTHOR), Sadallah, Salima³ (AUTHOR), Rotman, Samuel⁴ (AUTHOR), Venetz, Jean‐Pierre¹ (AUTHOR), Matter, Maurice⁵ (AUTHOR), Golshayan, Dela¹ (AUTHOR), Pascual, Manuel¹ (AUTHOR) manuel.pascual@chuv.ch
Source:	Xenotransplantation. Jul2020, Vol. 27 Issue 4, p1-5. 5p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!